Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 30

References for PMC Articles for PubMed (Select 18609711)

1.

Prognostic significance of matrix metalloproteinases-1, -2, -7 and -13 and tissue inhibitors of metalloproteinases-1, -2, -3 and -4 in colorectal cancer.

Hilska M, Roberts PJ, Collan YU, Laine VJ, Kössi J, Hirsimäki P, Rahkonen O, Laato M.

Int J Cancer. 2007 Aug 15;121(4):714-23.

PMID:
17455256
2.

The role of cadherin/catenin complex in malignant melanoma.

Bonitsis N, Batistatou A, Karantima S, Charalabopoulos K.

Exp Oncol. 2006 Sep;28(3):187-93. Review.

PMID:
17080010
3.

E-cadherin expression pattern in primary colorectal carcinomas and their metastases reflects disease outcome.

Elzagheid A, Algars A, Bendardaf R, Lamlum H, Ristamaki R, Collan Y, Syrjanen K, Pyrhonen S.

World J Gastroenterol. 2006 Jul 21;12(27):4304-9.

4.

Budding invasive margin and prognosis in colorectal cancer--no direct association with beta-catenin expression.

Hörkkö TT, Klintrup K, Mäkinen JM, Näpänkangas JB, Tuominen HJ, Mäkelä J, Karttunen TJ, Mäkinen MJ.

Eur J Cancer. 2006 May;42(7):964-71. Epub 2006 Mar 23.

PMID:
16563744
5.

Prognostic value of E-cadherin, beta-catenin, MMPs (7 and 9), and TIMPs (1 and 2) in patients with colorectal carcinoma.

Roca F, Mauro LV, Morandi A, Bonadeo F, Vaccaro C, Quintana GO, Specterman S, de Kier Joffé EB, Pallotta MG, Puricelli LI, Lastiri J.

J Surg Oncol. 2006 Feb 1;93(2):151-60.

PMID:
16425303
6.

Expression of sFRP-4 and beta-catenin in human colorectal carcinoma.

Feng Han Q, Zhao W, Bentel J, Shearwood AM, Zeps N, Joseph D, Iacopetta B, Dharmarajan A.

Cancer Lett. 2006 Jan 8;231(1):129-37.

PMID:
16356838
7.

E-cadherin, CD44s and CD44v6 correlate with tumour differentiation in colorectal cancer.

Bendardaf R, Elzagheid A, Lamlum H, Ristamäki R, Collan Y, Pyrhönen S.

Oncol Rep. 2005 May;13(5):831-5.

PMID:
15809746
8.

Nuclear beta-catenin accumulation as a prognostic factor in Dukes' D human colorectal cancers.

Miyamoto S, Endoh Y, Hasebe T, Ishii G, Kodama K, Goya M, Ono M, Saitoh N, Chiba T, Ochiai A.

Oncol Rep. 2004 Aug;12(2):245-51.

PMID:
15254684
9.

MUC1 and nuclear beta-catenin are coexpressed at the invasion front of colorectal carcinomas and are both correlated with tumor prognosis.

Baldus SE, Mönig SP, Huxel S, Landsberg S, Hanisch FG, Engelmann K, Schneider PM, Thiele J, Hölscher AH, Dienes HP.

Clin Cancer Res. 2004 Apr 15;10(8):2790-6.

10.

Convergence of Wnt, beta-catenin, and cadherin pathways.

Nelson WJ, Nusse R.

Science. 2004 Mar 5;303(5663):1483-7. Review.

11.

Prognostic and diagnostic significance of beta-catenin nuclear immunostaining in colorectal cancer.

Wong SC, Lo ES, Lee KC, Chan JK, Hsiao WL.

Clin Cancer Res. 2004 Feb 15;10(4):1401-8.

12.

beta-Catenin and ras oncogenes detect most human colorectal cancer.

Zhang B, Ougolkov A, Yamashita K, Takahashi Y, Mai M, Minamoto T.

Clin Cancer Res. 2003 Aug 1;9(8):3073-9.

13.

Irinotecan combined with bolus 5-fluorouracil and folinic acid Nordic schedule as first-line therapy in advanced colorectal cancer.

Glimelius B, Ristamäki R, Kjaer M, Pfeiffer P, Skovsgaard T, Tveit KM, Linné T, Frödin JE, Boussard B, Oulid-Aïssa D, Pyrhönen S.

Ann Oncol. 2002 Dec;13(12):1868-73.

14.
15.

The APC/beta-catenin pathway in ulcerative colitis-related colorectal carcinomas: a mutational analysis.

Aust DE, Terdiman JP, Willenbucher RF, Chang CG, Molinaro-Clark A, Baretton GB, Loehrs U, Waldman FM.

Cancer. 2002 Mar 1;94(5):1421-7.

16.

Oncogenic beta-catenin and MMP-7 (matrilysin) cosegregate in late-stage clinical colon cancer.

Ougolkov AV, Yamashita K, Mai M, Minamoto T.

Gastroenterology. 2002 Jan;122(1):60-71.

PMID:
11781281
17.

Tissue microarray analysis of beta-catenin in colorectal cancer shows nuclear phospho-beta-catenin is associated with a better prognosis.

Chung GG, Provost E, Kielhorn EP, Charette LA, Smith BL, Rimm DL.

Clin Cancer Res. 2001 Dec;7(12):4013-20.

18.
19.

Accumulation of beta-catenin protein and mutations in exon 3 of beta-catenin gene in gastrointestinal carcinoid tumor.

Fujimori M, Ikeda S, Shimizu Y, Okajima M, Asahara T.

Cancer Res. 2001 Sep 15;61(18):6656-9.

20.

Beta-catenin activation through mutation is rare in rectal cancer.

Nilbert M, Rambech E.

Cancer Genet Cytogenet. 2001 Jul 1;128(1):43-5.

PMID:
11454429
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk